Pfizer's European Lipitor Patent Extension: Likely In Some EU Countries
This article was originally published in The Pink Sheet Daily
Extra Lipitor sales from EU pediatric patent term extension difficult to quantify.
You may also be interested in...
A Year After It Wins Ratiopharm, Teva Reaps Rewards in Europe
For innovator firms, Europe has been about surviving multiple price cuts and government austerity measures. For generics firms, it has become a land of opportunity, where 2011 growth will outpace the overall pharmaceutical market.
Pipeline Watch: Phase III Readouts in Wilson Disease, Parkinson's Disease And COVID-19
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.